Sandbox:Sara: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(101 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__


<br />
{{CMG}}; {{AE}} {{S.M.}}
{| class="wikitable"
 
|+Measurement of UV protection afforded by sunscreens and clothing
 
!Measurement system
 
!'''SPF (Sun protection factor)'''  
<ref name="pmid27261907">{{cite journal| author=Mao Y, Yang D, He J, Krasna MJ| title=Epidemiology of Lung Cancer. | journal=Surg Oncol Clin N Am | year= 2016 | volume= 25 | issue= 3 | pages= 439-45 | pmid=27261907 | doi=10.1016/j.soc.2016.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27261907  }} </ref>
!'''UVA‐PF (UVA‐protection factor''')
 
!'''UPF (Ultraviolet protection factor)'''
[[File:Atypical Bcell gif.gif|thumb|200px|none|High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.[https://openi.nlm.nih.gov/detailedresult.php?img=PMC2944189_1752-1947-4-300-2&query=waldenstrom+macroglobulinaemia&it=xg&req=4&npos=17 Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.]]]
 
 
{|
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders'''
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS
|-
|-
|'''Definition'''
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein
|
| style="background:#F5F5F5;" align="center" + | +
|
| style="background:#F5F5F5;" align="center" + | +
|
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
|-
|-
|'''Developed for'''
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration
|
| style="background:#F5F5F5;" align="center" + | +
* Sunscreens
| style="background:#F5F5F5;" align="center" + | +
|
| style="background:#F5F5F5;" align="center" + | -
* Sunscreens
| style="background:#F5F5F5;" align="center" + | -
|
|-
|-
|'''Global acceptance'''
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM
|
| style="background:#F5F5F5;" align="center" + | +
* International
| style="background:#F5F5F5;" align="center" + | -
|
| style="background:#F5F5F5;" align="center" + | +
* United States only
| style="background:#F5F5F5;" align="center" + | -
|
|-
|-
|'''UV wavelengths protected'''
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration
|
| style="background:#F5F5F5;" align="center" + | +
* UVB
| style="background:#F5F5F5;" align="center" + | -
|
| style="background:#F5F5F5;" align="center" + | -
* UVA
| style="background:#F5F5F5;" align="center" + | -
|
|}<br />
|-
|'''Examples'''
|
* SPF 2 protects against 50% of UVB
* SPF 8 protects against 88% of UVB
* SPF 15 protects against  93% of UVB
* SPF 30 protects against 97% of UVB
* SPF 50 protects against 98% of UVB
|
* UVA‐PF1 protects against 20–39% of UVA
* UVA‐PF2 protects against 40–69% of UVA
* UVA‐PF3 protects against 70–95% of UVA
* UVA‐PF4 protects against >95% of UVA
|
|}
{{CMG}}; {{AE}} {{S.M.}}
 
 
 




Line 58: Line 47:




==References==
==Reference==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 18:18, 11 December 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]


[1]

High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.


Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -




Reference

  1. ↑ Mao Y, Yang D, He J, Krasna MJ (2016). "Epidemiology of Lung Cancer". Surg Oncol Clin N Am. 25 (3): 439–45. doi:10.1016/j.soc.2016.02.001. PMID 27261907.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sara&oldid=1678042"